Hong Kong · Delayed Price · Currency is HKD Sino Biopharmaceutical Statistics
Total Valuation
HKG:1177 has a market cap or net worth of HKD 125.85 billion. The enterprise value is 130.82 billion.
| Market Cap | 125.85B |
| Enterprise Value | 130.82B |
Important Dates
The next estimated earnings date is Sunday, November 30, 2025.
| Earnings Date | Nov 30, 2025 |
| Ex-Dividend Date | Aug 29, 2025 |
Share Statistics
HKG:1177 has 17.88 billion shares outstanding. The number of shares has decreased by -2.10% in one year.
| Current Share Class | 17.88B |
| Shares Outstanding | 17.88B |
| Shares Change (YoY) | -2.10% |
| Shares Change (QoQ) | -0.85% |
| Owned by Insiders (%) | 50.78% |
| Owned by Institutions (%) | 17.18% |
| Float | 8.80B |
Valuation Ratios
The trailing PE ratio is 29.84 and the forward PE ratio is 25.00. HKG:1177's PEG ratio is 0.95.
| PE Ratio | 29.84 |
| Forward PE | 25.00 |
| PS Ratio | 3.76 |
| PB Ratio | 2.51 |
| P/TBV Ratio | 3.80 |
| P/FCF Ratio | 19.55 |
| P/OCF Ratio | 17.15 |
| PEG Ratio | 0.95 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.18, with an EV/FCF ratio of 20.33.
| EV / Earnings | 30.84 |
| EV / Sales | 3.91 |
| EV / EBITDA | 17.18 |
| EV / EBIT | 20.91 |
| EV / FCF | 20.33 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.26.
| Current Ratio | 1.36 |
| Quick Ratio | 1.14 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 1.71 |
| Debt / FCF | 2.04 |
| Interest Coverage | 21.69 |
Financial Efficiency
Return on equity (ROE) is 15.40% and return on invested capital (ROIC) is 6.55%.
| Return on Equity (ROE) | 15.40% |
| Return on Assets (ROA) | 5.07% |
| Return on Invested Capital (ROIC) | 6.55% |
| Return on Capital Employed (ROCE) | 11.47% |
| Revenue Per Employee | 1.45M |
| Profits Per Employee | 183,989 |
| Employee Count | 24,379 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.83 |
Taxes
In the past 12 months, HKG:1177 has paid 942.53 million in taxes.
| Income Tax | 942.53M |
| Effective Tax Rate | 11.27% |
Stock Price Statistics
The stock price has increased by +98.87% in the last 52 weeks. The beta is 0.70, so HKG:1177's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +98.87% |
| 50-Day Moving Average | 8.04 |
| 200-Day Moving Average | 5.33 |
| Relative Strength Index (RSI) | 35.89 |
| Average Volume (20 Days) | 96,484,795 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1177 had revenue of HKD 33.49 billion and earned 4.24 billion in profits. Earnings per share was 0.23.
| Revenue | 33.49B |
| Gross Profit | 27.39B |
| Operating Income | 6.29B |
| Pretax Income | 8.36B |
| Net Income | 4.24B |
| EBITDA | 7.54B |
| EBIT | 6.29B |
| Earnings Per Share (EPS) | 0.23 |
Balance Sheet
The company has 21.72 billion in cash and 13.10 billion in debt, giving a net cash position of 8.62 billion or 0.48 per share.
| Cash & Cash Equivalents | 21.72B |
| Total Debt | 13.10B |
| Net Cash | 8.62B |
| Net Cash Per Share | 0.48 |
| Equity (Book Value) | 50.16B |
| Book Value Per Share | 2.04 |
| Working Capital | 9.83B |
Cash Flow
In the last 12 months, operating cash flow was 7.34 billion and capital expenditures -902.33 million, giving a free cash flow of 6.44 billion.
| Operating Cash Flow | 7.34B |
| Capital Expenditures | -902.33M |
| Free Cash Flow | 6.44B |
| FCF Per Share | 0.36 |
Margins
Gross margin is 81.77%, with operating and profit margins of 18.78% and 12.67%.
| Gross Margin | 81.77% |
| Operating Margin | 18.78% |
| Pretax Margin | 24.96% |
| Profit Margin | 12.67% |
| EBITDA Margin | 22.51% |
| EBIT Margin | 18.78% |
| FCF Margin | 19.22% |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 1.42%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 1.42% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 47.69% |
| Buyback Yield | 2.10% |
| Shareholder Yield | 3.52% |
| Earnings Yield | 3.37% |
| FCF Yield | 5.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 20, 2020. It was a forward split with a ratio of 1.5.
| Last Split Date | Jul 20, 2020 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
HKG:1177 has an Altman Z-Score of 2.54 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.54 |
| Piotroski F-Score | 6 |